Want to see IT:GPI full AI Analyst Report?
GPI Stock Chart & Stats
€16.62
€0.08(0.76%)
At close: 4:00 PM EST
€16.62
€0.08(0.76%)
Day’s Range― - ―
52-Week Range€11.20 - €18.68
Previous CloseN/A
Volume21.63K
Average Volume (3M)88.12K
Market Cap
€424.57M
Enterprise Value€794.70M
Total Cash (Recent Filing)€110.31M
Total Debt (Recent Filing)€485.46M
Price to Earnings (P/E)26.3
Beta0.29
Next Earnings
Sep 24, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield5.24%
Share Statistics
EPS (TTM)0.56
Shares Outstanding28,906,881
10 Day Avg. Volume56,776
30 Day Avg. Volume88,124
Financial Highlights & Ratios
PEG Ratio-0.34
Price to Book (P/B)1.51
Price to Sales (P/S)0.87
P/FCF Ratio26.76
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€16.50Price Target Upside-0.72% Downside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)0.97
Revenue Forecast (FY)€585.13M
Bulls Say, Bears Say
Bulls Say
Financial PerformanceGPI closed FY24 with better-than-expected results across the board amid better performances at the Other and Care divisions, while Software grew strongly and in line with expectations.
International ContractsGPI announced new international contracts worth € 15mn, including significant growth in the Software segment.
Revenue GrowthRevenues exceeded expectations with strong growth in the software segment, driven by both organic and external growth.
Bears Say
Bond IssuanceThe issuance of two senior unsecured bonds aims to finance investments and innovation, in line with the Industrial Plan.
Market CompetitivenessThe completion of the bond placement helps consolidate the financial structure in a context of gradually increasing competitiveness.
Market FragmentationThe project consolidates GPI's position in the pharmaceutical wholesale segment and is significant as a strategic reference in a highly fragmented market.
GPI FAQ
What was GPI SpA’s price range in the past 12 months?
GPI SpA lowest stock price was €11.20 and its highest was €18.68 in the past 12 months.
What is GPI SpA’s market cap?
GPI SpA’s market cap is €424.57M.
When is GPI SpA’s upcoming earnings report date?
GPI SpA’s upcoming earnings report date is Sep 24, 2026 which is in 84 days.
How were GPI SpA’s earnings last quarter?
GPI SpA released its earnings results on Mar 30, 2026. The company reported €0.432 earnings per share for the quarter, beating the consensus estimate of N/A by €0.432.
Is GPI SpA overvalued?
According to Wall Street analysts GPI SpA’s price is currently Overvalued.
Does GPI SpA pay dividends?
GPI SpA pays a Annually dividend of €0.601 which represents an annual dividend yield of 5.24%. See more information on GPI SpA dividends here
What is GPI SpA’s EPS estimate?
GPI SpA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does GPI SpA have?
GPI SpA has 28,906,881 shares outstanding.
What happened to GPI SpA’s price movement after its last earnings report?
GPI SpA reported an EPS of €0.432 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.693%.
Which hedge fund is a major shareholder of GPI SpA?
Currently, no hedge funds are holding shares in IT:GPI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
GPI SpA
GPI S.p.A. delivers specialized IT and high-tech services to the healthcare and social-healthcare markets. The company develops a wide range of software solutions covering critical areas such as health administration, clinical systems, social care, blood and tissue banking, human resource management, continuum care, public administration, safety and prevention, chronic illness management, patient care, business intelligence, data analytics, health cooperation, and people relationship management. Beyond software, GPI delivers key healthcare administration services, including advanced centralized booking and contract systems designed to significantly reduce patient waiting times, alongside innovative healthcare technologies and broader healthcare support. Their product portfolio features the Phasys System, an integrated hardware and software platform for optimizing medication management in healthcare facilities, and the RIEDL Phasys System, which automates medicine distribution within pharmacies. Furthermore, GPI offers general ICT services, payment solutions for both public administration and retail, and a comprehensive suite of desktop services. These desktop services encompass the design, implementation, and ongoing maintenance of technological infrastructures; IT consultancy and support; provision of solutions for public administrations; and help desk and facility management for a diverse clientele including local and central public bodies, healthcare providers, multi-utilities, and private enterprises. They also specialize in trouble ticketing systems and the design of integrated technological solutions. Established in 1988 and headquartered in Trento, Italy, GPI S.p.A. operates as a subsidiary of FM S.r.l.
GPI Stock 12 Month Forecast
Average Price Target
€16.50
▼(-0.72% Downside)
Technical Analysis
PharmaNutra SpA
―
Farmae SpA
―
I.M.D. International Medical Devices S.P.A.
―
Otofarma S.P.A.
―
Piu Medical S.P.A.
―
Options Prices
Currently, No data available
---







